Christine Beeton

Department of Physiology and Biophysics, University of California, Irvine (UCI)

Affiliated withUniversity of California, Irvine (UCI)Baylor College of Medicine

Research Area

Biography

Christine Beeton has not added Biography.
If you are Christine Beeton and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 10	Year
Publication title Cited by 27	2007
Publication title Cited by 18	2007
Publication title Cited by 87	2007
Publication title Cited by 13	2007
Publication title Cited by 8	2007

Other Publications

Article	Year
A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes. The Journal of biological chemistry\| PubMed ID: 12511563	2003
Myelin basic protein-reactive T cells induce conduction failure in vivo but not in vitro. Neuroreport\| PubMed ID: 12634475	2003
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. The Journal of clinical investigation\| PubMed ID: 12782673	2003
Potassium channels as therapeutic targets for autoimmune disorders. Current opinion in drug discovery & development\| PubMed ID: 14579513	2003
K+ channels as targets for specific immunomodulation. Trends in pharmacological sciences\| PubMed ID: 15120495	2004
Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Molecular pharmacology\| PubMed ID: 15155830	2004
Evidence for domain-specific recognition of SK and Kv channels by MTX and HsTx1 scorpion toxins. The Journal of biological chemistry\| PubMed ID: 15498765	2004
Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Molecular pharmacology\| PubMed ID: 15665253	2005
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 16043714	2005
The impact of the fourth disulfide bridge in scorpion toxins of the alpha-KTx6 subfamily. Proteins\| PubMed ID: 16247791	2005
Potassium channels, memory T cells, and multiple sclerosis. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry\| PubMed ID: 16282596	2005
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 17088564	2006
The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation. The Journal of biological chemistry\| PubMed ID: 17984097	2008
Discovery on Target 2007--CHI's Fifth Annual Conference. Ion channels. IDrugs : the investigational drugs journal\| PubMed ID: 18041678	2007
Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity\| PubMed ID: 18835197	2008
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nature communications\| PubMed ID: 21629267	2011
Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases. Inflammation & allergy drug targets\| PubMed ID: 21824083	2011
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. Toxicon : official journal of the International Society on Toxinology\| PubMed ID: 21867724	2011
KCa1.1 Potassium Channels Regulate Key Proinflammatory and Invasive Properties of Fibroblast-like Synoviocytes in Rheumatoid Arthritis. The Journal of biological chemistry\| PubMed ID: 22074915	2012